Verbatim response from Perplexity
Without insurance, GLP-1 medication costs per month range from $149 for compounded semaglutide or discounted oral versions to $1,350 for brand-name injectables like Wegovy, depending on the drug, dosage, and purchasing channel [1][3].
The cost varies significantly based on whether you choose a brand-name product or a compounded alternative:
| Category | Typical Monthly Cost (No Insurance) | Key Examples & Notes |
|---|---|---|
| Compounded Semaglutide | $129 – $149 | Via telehealth/compounding pharmacies; includes doctor visits [1][5]. |
| Brand-Namе Oral (Pill) | $149 – $299 | Wegovy pill: $149/month (starter/lower dose) via NovoCare [2][4]. |
| Brand-Namе Injectable (Self-Pay Programs) | $299 – $499 | Zepbound: $299–$449 (via LillyDirect) [2][9]; Wegovy/Ozempic pens: ~$349 (via NovoCare) [9][16]. |
| Brand-Namе Retail (Full List Price) | $900 – $1,350 | Wegovy: ~$1,349; Ozempic: ~$935–$1,029; Zepbound/Mounjaro: ~$1,023–$1,349 [1][6][10]. |
Key factors influencing price:
- Manufacturer Self-Pay Programs: Prices are significantly lower if you buy directly from the manufacturer (e.g., NovoCare for Novo Nordisk drugs, LillyDirect for Eli Lilly drugs) rather than a standard retail pharmacy. For example, Wegovy injectables are ~$349/month via NovoCare, compared to ~$1,349 at retail [9][16].
- Dosage: Starter doses (e.g., Zepbound 2.5 mg) are cheaper ($349/month) than maintenance doses ($499/month) [7][14].
- Compounding: Compounded versions are the cheapest option but are not FDA-approved as brand-name drugs and carry different regulatory standards [1][5].
Most legitimate self-pay paths for FDA-approved drugs settle between $299 and $449 once starter pricing ends or doses increase [2].